GCG and type 2 diabetes mellitus: The ‘reprogramming’ of at least a larger subset of alpha cells to produce GLP-1 instead of glucagon might be beneficial in the treatment of type 2 diabetes since GLP-1 is not only more efficient in enhancing GSIS, but it also does not affect hepatic glucose output.